NASDAQ
Clinuvel Pharmaceuticals Limited (CLVLY) has a free cash flow growth of -56.15% as of Friday, May 29, 2026. This represents a 279.71% decrease compared to its 12-month average of 31.24%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.